BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27596685)

  • 41. Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia.
    Wasihun Y; Asnake D; Kebede N
    BMC Infect Dis; 2024 May; 24(1):460. PubMed ID: 38693473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
    PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
    Bivigou-Mboumba B; François-Souquière S; Deleplancque L; Sica J; Mouinga-Ondémé A; Amougou-Atsama M; Chaix ML; Njouom R; Rouet F
    PLoS One; 2016; 11(1):e0143869. PubMed ID: 26764909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study.
    Lakoh S; Firima E; Jiba DF; Kamara MN; Gashau W; Deen GF; Adekanmbi O; Yendewa GA
    BMC Gastroenterol; 2021 Aug; 21(1):320. PubMed ID: 34372775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection.
    Belbacha I; Bensghir R; Filali Marhoum K; Laboudi M; Hajoutt K; Elharti E; Sadki K; Oumzil H
    J Infect Dev Ctries; 2024 May; 18(5):779-786. PubMed ID: 38865405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen.
    Aurpibul L; Kanjanavanit S; Leerapun A; Puthanakit T
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218823259. PubMed ID: 30798669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
    Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.
    Katwesigye E; Seremba E; Semitala F; Ocama P
    Afr Health Sci; 2017 Dec; 17(4):974-978. PubMed ID: 29937867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.
    Sterling RK; Wahed AS; King WC; Kleiner DE; Khalili M; Sulkowski M; Chung RT; Jain MK; Lisker-Melman M; Wong DK; Ghany MG;
    Am J Gastroenterol; 2019 May; 114(5):746-757. PubMed ID: 30410040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal.
    Ramírez Mena A; Ngom NF; Tine J; Ndiaye K; Fortes L; Ndiaye O; Fall M; Gaye A; Ka D; Seydi M; Wandeler G; On Behalf Of The Sen-B Study Group
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon.
    Molu JP; Essome MCN; Monamele CG; Njouom R
    BMC Res Notes; 2018 Jan; 11(1):39. PubMed ID: 29338763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia.
    Oshitani H; Kasolo FC; Mpabalwani M; Mizuta K; Luo NP; Suzuki H; Numazaki Y
    Trans R Soc Trop Med Hyg; 1996; 90(3):235-6. PubMed ID: 8758060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and predictors of liver disease in HIV-infected children and adolescents.
    Pokorska-Śpiewak M; Stańska-Perka A; Popielska J; Ołdakowska A; Coupland U; Zawadka K; Szczepańska-Putz M; Marczyńska M
    Sci Rep; 2017 Sep; 7(1):12309. PubMed ID: 28951598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.
    Li Y; Xie J; Han Y; Wang H; Lv W; Guo F; Qiu Z; Li Y; Du S; Song X; Zhu T; Thio CL; Li T
    Medicine (Baltimore); 2016 Feb; 95(5):e2660. PubMed ID: 26844493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk.
    Yang Y; Gao J; Tan YT; Li HL; Wang J; Ma X; Zheng W; Shu XO; Xiang YB
    J Gastroenterol Hepatol; 2018 May; 33(5):1131-1137. PubMed ID: 29065440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B serological markers and plasma DNA concentrations.
    Price H; Dunn D; Zachary T; Vudriko T; Chirara M; Kityo C; Munderi P; Spyer M; Hakim J; Gilks C; Kaleebu P; Pillay D; Gilson R;
    AIDS; 2017 May; 31(8):1109-1117. PubMed ID: 28328795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers.
    Xun YH; Zang GQ; Guo JC; Yu XL; Liu H; Xiang J; Liu J; Shi JP
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1746-55. PubMed ID: 23800140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.